Thursday, 27 January 2022

Australia's most trusted
source of pharma news

Thursday, 27 January 2022

Omicron kicks off new vax race

Posted 29 November 2021 PM

The race is on to develop a vaccine against the latest variant of COVID-19, Omicron, with the main vaccine developers offering reassurance that they are already on the case - and a new jab could be ready in early 2022.

The new variant of concern has been dubbed Omicron by the World Health Organisation, continuing its tradition of using Greek letters to make it simpler to communicate than using the scientific name, and avoiding offence by referring to the virus by the place it was first identified.

To see the whole article, please login

Email this article to a friend

Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.


Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.


Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).


You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.


You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.